New York, NY – According to filings with the U.S. Securities and Exchange Commission, Digital Therapeutics dba Quit Genius is raising $15,299,979.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Yusuf Sherwani played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Digital Therapeutics dba Quit Genius
Quit Genius is the worlds first digital clinic for treating nicotine, alcohol and opioid addictions. Built on the evidence-based principle of Medication-Assisted Treatment (MAT), Quit Genius combines virtual behavioral therapy with approved medication and connected devices to help employers tackle the high cost of addiction in the workplace while improving the lives of their employees.

To learn more about Digital Therapeutics dba Quit Genius, visit http://www.quitgenius.com/

Contact:
Yusuf Sherwani, Chief Executive Officer
877-349-7755
yusuf@quitgenius.com
https://www.linkedin.com/in/ysherwani/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved